JP2012205590A5 - - Google Patents

Download PDF

Info

Publication number
JP2012205590A5
JP2012205590A5 JP2012055519A JP2012055519A JP2012205590A5 JP 2012205590 A5 JP2012205590 A5 JP 2012205590A5 JP 2012055519 A JP2012055519 A JP 2012055519A JP 2012055519 A JP2012055519 A JP 2012055519A JP 2012205590 A5 JP2012205590 A5 JP 2012205590A5
Authority
JP
Japan
Prior art keywords
gene
genes
fatigue
homologous
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012055519A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012205590A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012055519A priority Critical patent/JP2012205590A/ja
Priority claimed from JP2012055519A external-priority patent/JP2012205590A/ja
Publication of JP2012205590A publication Critical patent/JP2012205590A/ja
Publication of JP2012205590A5 publication Critical patent/JP2012205590A5/ja
Pending legal-status Critical Current

Links

JP2012055519A 2011-03-16 2012-03-13 遺伝子発現を用いた疲労の判定方法 Pending JP2012205590A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012055519A JP2012205590A (ja) 2011-03-16 2012-03-13 遺伝子発現を用いた疲労の判定方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011057479 2011-03-16
JP2011057479 2011-03-16
JP2012055519A JP2012205590A (ja) 2011-03-16 2012-03-13 遺伝子発現を用いた疲労の判定方法

Publications (2)

Publication Number Publication Date
JP2012205590A JP2012205590A (ja) 2012-10-25
JP2012205590A5 true JP2012205590A5 (enExample) 2015-04-23

Family

ID=47185968

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012055519A Pending JP2012205590A (ja) 2011-03-16 2012-03-13 遺伝子発現を用いた疲労の判定方法

Country Status (1)

Country Link
JP (1) JP2012205590A (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109022466B (zh) * 2018-09-17 2021-07-23 中国人民解放军南京军区南京总医院 一种acta2-mitf融合基因及其检测引物和应用
JP7555124B2 (ja) 2019-07-11 2024-09-24 国立大学法人神戸大学 神経芽腫の微小残存病変マーカーを用いた生体試料の分析方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005124565A (ja) * 2003-09-29 2005-05-19 Sogo Ikagaku Kenkyusho:Kk 新規神経ペプチド及びその利用
JP2007228878A (ja) * 2006-03-01 2007-09-13 Hitachi Ltd 慢性疲労症候群の診断方法
JP2007306883A (ja) * 2006-05-22 2007-11-29 Hitachi High-Technologies Corp 慢性ストレスの評価方法
JP2008054590A (ja) * 2006-08-31 2008-03-13 Hitachi High-Technologies Corp 運動ストレス状態の評価方法
JP5553515B2 (ja) * 2009-02-13 2014-07-16 英 龍治 精神的ストレス抑制物質又は精神的ストレス増強物質のスクリーニング方法、精神的ストレス抑制もしくは増強物質スクリーニング用キット、哺乳動物の精神的ストレスの判定方法、患者のうつ病の判定又は同病からの回復の判定の際に使用するデータの収集方法、及び、精神的ストレスまたはうつ病の判定キット
JP2010187547A (ja) * 2009-02-13 2010-09-02 National Institute Of Advanced Industrial Science & Technology 精神疾患の診断方法
JP5553525B2 (ja) * 2009-04-17 2014-07-16 敦生 関山 生体負荷の指標剤および生体負荷の測定方法
JP2011004693A (ja) * 2009-06-29 2011-01-13 National Institute Of Advanced Industrial Science & Technology 精神疾患の診断方法(Amy1a遺伝子)
JP5077332B2 (ja) * 2009-11-30 2012-11-21 ソニー株式会社 ストレス評価方法

Similar Documents

Publication Publication Date Title
JP2011511804A5 (enExample)
Hehar et al. The use of telomere length as a predictive biomarker for injury prognosis in juvenile rats following a concussion/mild traumatic brain injury
JP6499306B2 (ja) ランチオニンシンテターゼc様2系治療薬
JP2011510650A5 (enExample)
AR111487A1 (es) Métodos para predecir la falta de respuesta a un tratamiento anti-tnf en sujetos con enfermedad inflamatoria intestinal
JP2014519487A5 (enExample)
WO2018231851A1 (en) Methods of treating liver fibrosis
KR20160009582A (ko) 크론병과 연관된 tnfsf15와 dcr3의 변이체
Luft Hypertension as a complex genetic trait
JP2017503481A5 (enExample)
Battina et al. Interaction of the inflammatory response and megakaryocytes in COVID-19 infection
JP2012205590A5 (enExample)
IL294596A (en) Method of using genetic markers, snps and/or indels to determine responsiveness to il-10 treatment
JPWO2019220412A5 (enExample)
JP2012019784A5 (enExample)
WO2023215618A2 (en) Methods for identifying shared biological pathways between diseases using mendelian randomization
Cerit The effects of the Angiotensin-Converting Enzyme (ACE) genotype on 3000 m running (VO2max) performance & body composition in Turkish Army Soldiers: longitudinal study
JP2009528030A5 (enExample)
Žukauskaitė et al. Detection of recent positive selection signatures in the cohort of Lithuanian Chernobyl catastrophe liquidators
Meckel et al. High Prevalence of the ACSL (rs6552828) AA Genotype among Elite Soccer Players
Mehrtashfar et al. Association of enos 894 g> t gene polymorphism and risk of coronary artery disease in iranian population
Ge et al. IL-17 and IL-22 Positive Innate Lymphoid Cells Mediate Early Immunization of Lung Mass Type Tuberculosis
ul Haq et al. Knowledge, attitude and practice towards hepatitis B among medical college students of Quetta, Pakistan
Szczerkowska‐Dobosz et al. The age of onset of psoriasis and the relationship to clinical presentation of psoriasis: study of 404 patients from northern Poland.
Baragetti et al. Leukocyte telomere length, genetically determined, is causally associated with the progression of carotid Intima-Media Thickness and incidence of cardiovascular events